AstraZeneca

AstraZeneca adds Latin America to Ionis ATTR partnership for $20M
Fierce Biotech
Fri, 07/28/23 - 11:48 am
AstraZeneca
Ionis Pharmaceuticals
Latin American
eplontersen
ATTR
AstraZeneca buys Pfizer’s early gene therapy work for up to $1B
BioPharma Dive
Fri, 07/28/23 - 10:45 am
AstraZeneca
Pfizer
M&A
gene therapy
AstraZeneca enlists SK Chemicals to produce diabetes combo drug Sidapvia
Fierce Pharma
Mon, 07/24/23 - 09:42 pm
AstraZeneca
SK Chemicals
Korea
Sidapvia
diabetes
drug manufacturing
Scratching the surface of the urticaria pipeline
EP Vantage
Thu, 07/20/23 - 10:00 am
chronic urticaria
Sanofi
Dupixent
Regeneron
Novartis
Roche
Xolair
Allakos
AstraZeneca
Celldex Therapeutics
Pieris wields axe after losing AZ as partner for elarekibep
Pharmaphorum
Wed, 07/19/23 - 10:13 am
Pieris
AstraZeneca
elarekibep
layoffs
CDC vaccine committee sets August date to weigh use of Sanofi, AZ's RSV antibody Beyfortus
Fierce Pharma
Tue, 07/18/23 - 10:06 pm
CDC
Sanofi
AstraZeneca
RSV
Beyfortus
FDA Approves Sanofi and AstraZeneca’s RSV Antibody for Newborns, Infants
BioSpace
Mon, 07/17/23 - 07:00 pm
Sanofi
AstraZeneca
Beyfortus
nirsevimab
RSV
infants
pediatric
FDA
AstraZeneca stock slides as pivotal lung cancer readout on Daiichi-partnered ADC spooks investors
Fierce Biotech
Mon, 07/3/23 - 11:40 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
clinical trials
non-small cell lung cancer
AstraZeneca’s liver cancer treatment shows ‘continued survival benefit’ in phase 3 trial
Biopharma Reporter
Mon, 07/3/23 - 10:46 am
AstraZeneca
Imfinzi
liver cancer
clinical trials
AstraZeneca sows $400M investment in push to plant 200M trees by 2030
Fierce Pharma
Wed, 06/28/23 - 10:49 am
AstraZeneca
environmental concerns
ESG
5 FDA decisions to watch in the third quarter
BioPharma Dive
Mon, 06/26/23 - 10:04 am
FDA
SAGE Therapeutics
Biogen
zuranolone
Eisai
Leqembi
Sanofi
AstraZeneca
nirsevimab
Iveric Bio
Zimura
Alnylam
Onpattro
Alphabet's quantum spinoff starts working with AstraZeneca, Sanofi to accelerate R&D
Fierce Biotech
Fri, 06/23/23 - 10:01 am
Alphabet
SandboxAQ
AstraZeneca
Sanofi
R&D
funding
molecular simulation
artificial intelligence
Pfizer's Talzenna snags broader prostate cancer nod than AstraZeneca and Merck's rival PARP med
Fierce Pharma
Thu, 06/22/23 - 10:12 am
Pfizer
FDA
prostate cancer
Talzenna
AstraZeneca
PARP inhibitors
Merck
Pieris stock deflates as AstraZeneca stops trials of asthma drug in response to toxicology signal
Fierce Biotech
Wed, 06/21/23 - 10:54 am
AstraZeneca
Pieris
clinical trials
asthma
elarekibep
'Misinformation': AstraZeneca's China head refutes news report about potential spinoff
Fierce Pharma
Tue, 06/20/23 - 09:36 pm
AstraZeneca
China
AstraZeneca drops another GLP-1 after phase 1 data bust market-beating diabetes hopes
Fierce Biotech
Tue, 06/20/23 - 10:15 am
AstraZeneca
GLP-1 agonist
AZD0186
type 2 diabetes
AstraZeneca planning China business spin off
Yahoo/Reuters
Tue, 06/20/23 - 10:07 am
AstraZeneca
China
AstraZeneca returns to hypercholesterolemia via R&D pact with fresh-faced Chinese biotech
Fierce Biotech
Fri, 06/16/23 - 09:59 am
AstraZeneca
hypercholesterolemia
R&D
Cholesgen
Biopharma Confronts a Rising Tide of Ransomware Attacks
BioSpace
Wed, 06/14/23 - 10:11 am
cyberattacks
cybersecurity
ransomware
Eisai
Sun Pharma
Novartis
AstraZeneca
Merck
From farm to pharma: AstraZeneca inks renewable natural gas pact to shrink environmental footprint
Fierce Pharma
Tue, 06/13/23 - 10:50 pm
AstraZeneca
sustainability
carbon emissions

Pages